SCHEMBL26192501

SCHEMBL26192501

COc1cc2c(cc1OCc1ccccc1)-c1cc3ccc(OC)c(C)c3c[n+]1CC2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COL1A1 P02452 4/20 0.67
NR1H4 Q96RI1 1/20 0.67
ACHE P22303 12/20 0.65
BCHE P06276 10/20 0.65
PREP P48147 10/20 0.65
KDM4E B2RXH2 3/20 0.61
MAPT P10636 3/20 0.61
CYP3A4 P08684 2/20 0.61
MAPK1 P28482 2/20 0.61
RAD52 P43351 2/20 0.61
EP300 Q09472 2/20 0.61
KDM1A O60341 2/20 0.61
LMNA P02545 2/20 0.61
CYP2D6 P10635 1/20 0.61
HIF1A Q16665 1/20 0.61
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
POLB P06746 1/20 0.53
HPGD P15428 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26192141 0.89 COL1A1 (0.68) COL1A1NR1H4ACHEBCHEPREP
SCHEMBL26192504 0.89 ACHE (0.62) COL1A1NR1H4ACHEBCHEPREP
SCHEMBL26291523 0.82 ACHE (0.64) COL1A1NR1H4ACHEBCHEPREP
SCHEMBL26192808 0.79 ACHE (0.70) COL1A1NR1H4ACHEBCHEPREP
SCHEMBL910108 0.79 BCHE (1.00) ACHEBCHEPREP
SCHEMBL26192506 0.78 RAC1 (0.62) COL1A1NR1H4ACHEBCHEKDM4E
SCHEMBL27147420 0.77 CYP3A4 (0.85) COL1A1NR1H4ACHEBCHEKDM4E
Palmitine SCHEMBL562120 0.77 CYP3A4 (1.00) COL1A1NR1H4ACHEBCHEKDM4E
Palmitine SCHEMBL29471136 0.77 CYP3A4 (1.00) COL1A1NR1H4ACHEBCHEKDM4E
Palmitine SCHEMBL29350054 0.77 CYP3A4 (1.00) COL1A1NR1H4ACHEBCHEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271982-A1 CODRUG THAT DISINTEGRATES IN INTESTINE, PREPARATION THEREFOR, AND USE THEREOF SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD. (CN) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271982-A1 CODRUG THAT DISINTEGRATES IN INTESTINE, PREPARATION THEREFOR, AND USE THEREOF VIP, SI, PDCD5 COL1A1 3111/4885NR1H4 22/4885ACHE 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.